ADBIOTECH Completes Cash Acquisition of 12.28% Stake in Onhill, Equity Increases by 9.97B KRW

ADBIOTECH reported the completion of acquiring 181,269 common shares of Onhill Co., Ltd. representing a 12.28% voting stake, for a cash consideration of 9.97 billion KRW on July 3, 2026.
The acquisition was fully cash-funded without issuing new shares, thus causing no dilution to existing shareholders.
After the completion, ADBIOTECH's non-current assets increased by 9.97 billion KRW and total equity rose by the same amount, improving the debt ratio, though this may be an accounting effect.
The company still carries negative retained earnings of minus 27.67 billion KRW, and no specific synergy or growth strategy for this investment has been disclosed.
[AI Summary]ADBIOTECH spent 9.97 billion KRW in cash to secure a 12.28% stake in Onhill, but the profitability and strategic value of the investment remain unclear. While no share dilution occurred, the large cash outflow could strain financial resources, and future performance of Onhill and the partnership will be key stock price drivers.